Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Ophthalmology

Protecting Your Vision: Monitoring & Warning Signs

At a Glance

Regular eye visits for idiopathic scleritis can detect serious complications such as scleral thinning, corneal damage, retinal fluid, and steroid-related high eye pressure. Sudden vision loss or rapidly worsening severe eye pain requires same-day assessment.

Living with idiopathic scleritis requires a balance between patience and vigilance. While many cases are successfully managed with treatment, the condition can be unpredictable. Monitoring involves not only tracking the inflammation in your eye but also watching for structural changes and side effects from medications [1][2].

Recognizing True Emergencies

New or worsening symptoms may require prompt review, so you must be able to recognize red flags that require a same-day ophthalmic assessment (or an emergency department visit if your specialist is unavailable).

Seek immediate medical assessment if you experience:

  • Sudden Vision Loss: Any rapid blurring, missing areas of vision, or a “curtain” over your vision [3].
  • Severe, Escalating Pain: A sudden, severe increase in eye pain that is not relieved by your usual medication [4].
  • Suspected Eye Thinning or Perforation: While a doctor uses a microscope to accurately diagnose scleral melting or necrosis, if you suspect your eye structure is changing drastically, seek help [5][6].
  • Hypopyon or Discharge: A visible pool of white or yellow fluid level at the bottom of the front part of your eye, or thick mucopurulent discharge [7].
  • Major Corneal Changes: Any sudden, noticeable new clouding or severe light sensitivity [8].

Structural Complications of the Disease

Even with treatment, chronic inflammation can lead to permanent changes in the eye’s anatomy, which your clinician will evaluate during exams.

  • Scleral Thinning and Ectasia: Over time, the sclera can become thin and weak, causing it to bulge outward (ectasia) [9].
  • Staphyloma: This is a more advanced bulge where the inner layers of the eye protrude through the thinned sclera [6].
  • Corneal Involvement: Scleritis can spread to the cornea, causing peripheral ulcerative keratitis (PUK)—a serious thinning of the cornea that can also threaten your vision [10][8].
  • Posterior Issues: In posterior scleritis, fluid can collect under the retina (exudative retinal detachment) or the optic nerve can swell, leading to permanent blind spots [11][3].

Complications from Treatment

The very medications used to save your vision can sometimes cause their own set of challenges, particularly corticosteroids (prednisone).

  • Glaucoma (Steroid-Induced High Pressure): Systemic or ocular steroids can prevent fluid from draining normally out of the eye, leading to high intraocular pressure (IOP). If left untreated, this pressure can damage the optic nerve [12][13].
  • Cataracts: Long-term steroid use is a known cause of cataracts (clouding of the eye’s natural lens) [14]. While cataracts are treatable with surgery, doctors usually wait until the scleritis has been quiet for several months before performing the procedure [13].

Your Monitoring Schedule

Routine monitoring is the “safety net” that catches these complications early. You can expect your visits to include:

  1. Visual Acuity Test: Checking if your vision is stable [15].
  2. Slit-Lamp Exam: A high-magnification look at the sclera and cornea to check for thinning [10].
  3. IOP Check: Measuring the pressure inside your eye to screen for glaucoma [12].
  4. Dilated Exam: Looking at the back of the eye for retinal fluid or nerve swelling [3].
  5. Systemic Monitoring: Systemic medications may require monitoring of CBC, liver/kidney tests, blood pressure, glucose, and bone health, as directed by your prescribing physician.

The Psychological Impact of “Wait and See”

It is normal to feel a sense of “waiting for the other shoe to drop.” Research indicates that approximately 38% of patients initially diagnosed with idiopathic scleritis will eventually be diagnosed with a specific systemic disease (like vasculitis or rheumatoid arthritis) later on in one specific study cohort (median follow-up 42 months) [16][17].

While this statistic can be daunting, it also highlights the value of your monitoring. Catching a systemic condition early through your eye symptoms often allows for better management of your overall health [16]. If your tests remain clear, your diagnosis stays “idiopathic”—and while we may not know the why, your care team’s focus remains on the how: protecting your vision and your comfort [18].

Common questions in this guide

Which changes from idiopathic scleritis need same-day medical attention?
Seek same-day eye care for sudden vision loss, a curtain or missing area in your vision, or a rapid increase in severe eye pain. New corneal clouding, marked light sensitivity, a white or yellow fluid level in the front of the eye, or thick discharge also need urgent assessment. If your eye specialist is unavailable, go to an emergency department.
Can idiopathic scleritis permanently damage the eye?
Yes. Ongoing inflammation can thin and weaken the sclera, cause an outward bulge or an advanced bulge called a staphyloma, or spread to the cornea and cause a serious thinning problem called peripheral ulcerative keratitis. Posterior scleritis can also lead to fluid beneath the retina or optic nerve swelling, which may cause lasting blind spots or vision loss.
What eye problems can prednisone or other steroids cause?
Corticosteroids can raise the pressure inside the eye, a problem that may damage the optic nerve and lead to glaucoma if untreated. Long-term use can also cause cataracts, or clouding of the eye’s natural lens. Regular pressure and eye examinations help detect these complications early.
What happens during follow-up visits for idiopathic scleritis?
Visits commonly include a vision test, a slit-lamp examination to inspect the sclera and cornea, and a pressure measurement. A dilated examination may check for fluid under the retina or optic nerve swelling. If you take systemic medicine, your clinician may also order blood counts, liver or kidney tests, blood pressure, glucose, or bone-health monitoring.
Can an idiopathic scleritis diagnosis later be linked to another disease?
Sometimes. In one study cohort, about 38% of people initially labeled as having idiopathic scleritis were later diagnosed with a specific systemic condition, such as vasculitis or rheumatoid arthritis, during follow-up. This finding does not predict what will happen to one person, but it supports reporting new joint pain, rashes, or ongoing sinus problems.
What should I track between scleritis appointments?
Record changes in pain, vision, eye appearance, and the timing and doses of your medicines. Tell your clinician about a new dark or bluish area on the white of the eye, joint pain, skin rashes, or persistent sinus symptoms. A symptom log can help your care team judge whether inflammation or treatment side effects are changing.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Do you see any signs of scleral thinning or 'melting' during my exam today?
  2. 2.Has my intraocular pressure (IOP) increased since starting my current medications?
  3. 3.Based on my progress, how frequently should I be coming in for monitoring visits?
  4. 4.Are there any new systemic symptoms I should be watching for that might indicate a move from 'idiopathic' to a specific autoimmune diagnosis?
  5. 5.If I experience a sudden increase in pain or a change in my vision, what is the best way to reach your team for a same-day assessment?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy.

    Fabiani C, Sota J, Sainz-de-la-Maza M, et al.

    Mediators of inflammation 2020; (2020()):8294560 doi:10.1155/2020/8294560.

    PMID: 32410867
  2. 2

    Clinical characteristics and efficacy of methotrexate in Japanese patients with noninfectious scleritis.

    Hiyama T, Harada Y, Kiuchi Y

    Japanese journal of ophthalmology 2021; (65(1)):97-106 doi:10.1007/s10384-020-00778-5.

    PMID: 33107015
  3. 3

    Exudative Retinal Detachment in Ocular Inflammatory Diseases: Risk and Predictive Factors.

    Shah DN, Al-Moujahed A, Newcomb CW, et al.

    American journal of ophthalmology 2020; (218()):279-287 doi:10.1016/j.ajo.2020.06.019.

    PMID: 32621891
  4. 4

    Case report-immune recovery posterior scleritis in a HIV positive patient.

    Che X, Jiang J, Qian Y, et al.

    BMC ophthalmology 2020; (20(1)):262 doi:10.1186/s12886-020-01529-3.

    PMID: 32615955
  5. 5

    [Diagnosis and treatment approach for necrotizing scleritis (NS): A clinical case].

    Hernández-Camarena JC, Rodríguez-García A, Valdez-García J

    Gaceta medica de Mexico 2015; (151(4)):525-8.

    PMID: 26290030
  6. 6

    Isolated ANCA-associated scleritis successfully treated with systemic rituximab; a case report and review of literature.

    Tahavvori M, Fekri S, Hassanpour K, et al.

    BMC ophthalmology 2025; (25(1)):176 doi:10.1186/s12886-025-04027-6.

    PMID: 40197146
  7. 7

    Infectious Scleritis: Pathophysiology, Diagnosis, and Management.

    Yu J, Syed ZA, Rapuano CJ

    Eye & contact lens 2021; (47(8)):434-441 doi:10.1097/ICL.0000000000000813.

    PMID: 34224444
  8. 8

    Ocular complications and mortality in peripheral ulcerative keratitis and necrotising scleritis: The role of systemic immunosuppression.

    Ogra S, Sims JL, McGhee CNJ, Niederer RL

    Clinical & experimental ophthalmology 2020; (48(4)):434-441 doi:10.1111/ceo.13709.

    PMID: 31872475
  9. 9

    Autologous Pericranium Graft for Necrotizing Scleritis.

    Copete S, Fagúndez-Vargas MA, López-Martínez F, et al.

    Cornea 2024; (43(12)):1567-1569 doi:10.1097/ICO.0000000000003643.

    PMID: 39079757
  10. 10

    Current Approach for the Diagnosis and Management of Noninfective Scleritis.

    Dutta Majumder P, Agrawal R, McCluskey P, Biswas J

    Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2020; (10(2)):212-223 doi:10.1097/APO.0000000000000341.

    PMID: 33290287
  11. 11

    Clinical Features, Treatment, and Visual Outcomes of Posterior Scleritis from Tertiary Eye Care Center.

    Tellioğlu A, Yargı Özkoçak B, Kemer Atik B, et al.

    Ocular immunology and inflammation 2024; (32(7)):1323-1329 doi:10.1080/09273948.2023.2241556.

    PMID: 37549312
  12. 12

    Clinical characteristics and ocular complications of patients with scleritis in Japanese.

    Tanaka R, Kaburaki T, Ohtomo K, et al.

    Japanese journal of ophthalmology 2018; (62(4)):517-524 doi:10.1007/s10384-018-0600-y.

    PMID: 29796754
  13. 13

    Cataract Surgery in the Setting of Scleritis.

    Palkar A, Sudharshan S, George AE, et al.

    Ocular immunology and inflammation 2021; (29(7-8)):1540-1543 doi:10.1080/09273948.2020.1754434.

    PMID: 32463347
  14. 14

    Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review.

    Dammacco R, Guerriero S, Alessio G, Dammacco F

    International ophthalmology 2022; (42(2)):689-711 doi:10.1007/s10792-021-02058-8.

    PMID: 34802085
  15. 15

    Methotrexate for the treatment of noninfectious scleritis.

    Sands DS, Chan SCY, Gottlieb CC

    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2018; (53(4)):349-353 doi:10.1016/j.jcjo.2017.11.009.

    PMID: 30119788
  16. 16

    Scleritis and associated systemic diseases: contribution of systemic examination, follow-up, and additional investigations.

    Soubrier M, Vasseneix C, Jacquot R, et al.

    Journal of ophthalmic inflammation and infection 2025; (16(1)):7 doi:10.1186/s12348-025-00566-7.

    PMID: 41447412
  17. 17

    ANCA-associated scleritis: impact of ANCA on presentation, response to therapy and outcome.

    Perray L, Nguyen Y, Clavel Refregiers G, et al.

    Rheumatology (Oxford, England) 2024; (63(2)):329-337 doi:10.1093/rheumatology/kead252.

    PMID: 37233203
  18. 18

    Scleritis and Development of Immune-Mediated Disease: A Retrospective Chart Review.

    Morrison T, Gottman M, Do T, et al.

    The Journal of rheumatology 2024; (51(8)):825-830 doi:10.3899/jrheum.2023-0788.

    PMID: 38302174

This page explains warning signs and monitoring for idiopathic scleritis for informational purposes only and does not constitute medical advice. Your ophthalmologist should interpret your symptoms, examination findings, and medication risks.

Get notified when new evidence is published on Idiopathic scleritis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.